Clinical Trial Update: Buprenorphine for Treatment Resistant Depression [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating buprenorphine for treatment-resistant depression has completed. Results were posted in March 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: University of Pittsburgh | Conditions: Depression, Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2016-03-17